Nutex Health, Inc. — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clinigence Holdings, Inc. (CLNH)
CIK: 0001479681
Period of Report: 2021-02-25

Reporting Person: Fawcett Mark (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-28	Common Stock	J	268263	$2.04	Acquired	277259	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-05	Director Stock Option (right to buy)	$	P	85120	Acquired		Common Stock (85120)	Direct
2019-03-21	Warrants to Puchase common stock	$6.67	P	3598	Acquired	2024-12-31	Common Stock (3598)	Direct

Footnotes

F1: Acquired as per Merger Transaction exchange

F2: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029
45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027
30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024